SCHEMBL240380

SCHEMBL240380

CCCCCCCC[N+](C)(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNM1 Q05193 7/20 1.00
▸ APAF1 O14727 1/20 0.88
▸ HSP90AA1 P07900 1/20 0.88
▸ RAD52 P43351 1/20 0.88
▸ MEN1 O00255 4/20 0.73
▸ KMT2A Q03164 4/20 0.73
▸ APEX1 P27695 3/20 0.73
▸ NFKB1 P19838 2/20 0.73
▸ KDM4E B2RXH2 2/20 0.73
▸ ACHE P22303 2/20 0.73
▸ SMN1; SMN2 Q16637 2/20 0.73
▸ PMP22 Q01453 2/20 0.73
▸ LMNA P02545 2/20 0.73
▸ HSD17B10 Q99714 1/20 0.73
▸ HRH3 Q9Y5N1 1/20 0.73
▸ TSHR P16473 1/20 0.73
▸ RAB9A P51151 1/20 0.73
▸ NPSR1 Q6W5P4 1/20 0.69
▸ HTT P42858 1/20 0.67
▸ SLC22A1 O15245 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8381506 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1
SCHEMBL5304747 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1
SCHEMBL2126215 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1
SCHEMBL142681 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1
SCHEMBL11758148 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1
Cetrimonium SCHEMBL23412540 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1
SCHEMBL119448 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1
SCHEMBL93498 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1
SCHEMBL48999 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1
SCHEMBL2266508 1.00 DNM1 (1.00) DNM1APAF1HSP90AA1RAD52MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1567 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090734-A1 METHOD FOR REMOVAL OF CONTAMINANTS FROM WATER AND RESOURCE RECOVERY THROUGH USE OF COLLOIDAL GAS APHRONS L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) 2025-05-01 — — WO claimed
US-20250113829-A1 HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS nanoSUR LLC 2025-04-10 — — US claimed
EP-4048751-B1 POLISHING COMPOSITION AND METHOD WITH HIGH SELECTIVITY FOR SILICON NITRIDE AND POLYSILICON OVER SILICON OXIDE CMC MAT LLC (US) 2025-03-19 — — EP claimed
WO-2025049143-A1 IONIZABLE PILLARARENE ANTICOAGULANT UNIVERSITY OF MARYLAND, COLLEGE PARK (US) 2025-03-06 — — WO claimed
US-20240409421-A1 SILICON-ALUMINUM ZEOLITE SCM-36, MANUFACTURING METHOD THEREFOR AND APPLICATION THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2024-12-12 — — US claimed
US-12146089-B2 Nanostructure ink compositions for inkjet printing SHOEI CHEMICAL INC. (JP) 2024-11-19 — — US claimed
CN-118126780-B Kitchen disinfection detergent and preparation method thereof 江苏爱特福84股份有限公司 2024-11-05 — — CN claimed
CN-118613517-A Preparation and use of polyisocyanates containing iminooxadiazinedione groups 巴斯夫欧洲公司 2024-09-06 — — CN claimed
CN-114599746-B Nanostructured ink compositions for inkjet printing 昭荣化学工业株式会社 2024-09-03 — — CN claimed
EP-4417577-A1 SILICON-ALUMINUM MOLECULAR SIEVE SCM-36, MANUFACTURING METHOD THEREFOR AND APPLICATION THEREOF China Petroleum & Chemical Corporation (CN) 2024-08-21 — — EP claimed
US-6107249-A LOW FOAM, PHYSICALLY STABLE COMPOSITION OF N-PHOSPHONOMETHYLGLYCINE OR WATER SOLUBLE SALT THEREOF; AN ALKYLGLYCOSIDE SURFACTANT, AND A QUATERNARY AMMONIUM SALT SURFACTANT OF GIVEN FORMULA ZENECA LIMITED (GB) 2000-08-22 — — US claimed
EP-0599188-B1 Trans and CIS traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity LIFEGROUP SPA (IT) 1997-08-06 — — EP claimed
US-5567716-A FOR THE THERAPEUTIC TREATMENT OF CUTANEOUS PATHOLOGIES LIFEGROUP S.P.A. (IT) 1996-10-22 — — US claimed
EP-0599188-A1 Trans and CIS traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity LIFEGROUP S.p.A. (IT) 1994-06-01 — — EP claimed
US-4913886-A FORMING AQUEOUS MIXTURE OF VOLATILE ORGANIC LIQUID, COPPER, ALUMINUM, BORON COMPOUNDS; DRYING, CALCINING AMOCO CORPORATION (US) 1990-04-03 — — US claimed
EP-0209256-B1 ANTISTATIC AGENTS FOR SYNTHETIC FIBERS Takemoto Yushi Kabushiki Kaisha (JP) 1988-12-07 — — EP claimed
EP-0141371-B1 SECONDARY BATTERY SHOWA DENKO KABUSHIKI KAISHA (JP) 1988-08-10 — — EP claimed
EP-0209256-A1 Antistatic agents for synthetic fibers Takemoto Yushi Kabushiki Kaisha (JP) 1987-01-21 — — EP claimed
US-4537843-A ELECTRODES OF POLYMER WITH CONJUGATED DOUBLE BONDS IN MAIN CHAIN, SHOWA DENKO KABUSHIKI KAISHA (JP) 1985-08-27 — — US claimed
EP-0141371-A1 Secondary Battery SHOWA DENKO KABUSHIKI KAISHA (JP) 1985-05-15 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250113829-A1 HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS NSUN2, NSUN3, RNGTT DNM1 1601/4885APAF1 1568/4885HSP90AA1 1395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback